PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2018SHILAP Revista de lepidopterología245 citationsOpen Access

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

YWYinghong WangHAHamzah Abu‐SbeihEMEmily Mao

Key Points

Key points are not available for this paper at this time.

Abstract

Patients with ICPI-induced diarrhea or colitis have improved survival outcomes. Diarrhea is an independent predictor of an improved survival regardless of treatment requirement. Immunosuppressive treatment for diarrhea did not significantly affect overall survival, however, infection rates were numerically higher among patients who received steroids for a long duration. Therefore, early non-steroid immunosuppressive therapy may ensure a more favorable overall outcome.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2018) studied this question.

synapsesocial.com/papers/69d94a919a6164e50fa3c78bhttps://doi.org/10.1186/s40425-018-0346-6
Ask AI
Helpful
Bookmark
Share
View Full Paper